FDA Inspection 865961 — Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site)
The FDA completed an inspection of Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) on December 13, 2013 in Hanzhong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 13, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hanzhong (China)